SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Updated VIKTORIA-1 Phase 3 breast-cancer data presented at ESMO is driving attention, especially the triplets reported 21.5-month median progression-free survival versus 9.1 months for the comparator in patients without liver metastases. Traders are largely enthusiastic about the results, while some caution that subgroup findings and the pending FDA decision on a PIK3CA-mutant label expansion leave uncertainty.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAO is being discussed amid a broader crypto pullback, with traders pointing to geopolitical uncertainty and oil-market concerns as possible sources of risk-off pressure. Long-term believers are buying dips on Bittensors decentralized-AI and subnet potential, while cautious traders question whether adoption and revenue justify the valuation.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is drawing attention for its prolonged weakness and choppy trading, with traders noting repeated failures to hold the eight-cent area and linking moves to broader crypto-market direction. Reactions are split between dip-buying and long-term holding, and frustration over losses and the lack of momentum.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstops steep selloff and fresh lows are drawing attention amid concerns about declining same-store sales, softer restaurant traffic and strained consumer spending, with traders also citing oil and cost pressures. The community is split between buyers calling the drop an opportunity and bears expecting further downside as sales growth weakens.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins sharp pullback below a key psychological threshold and reports of sizable leveraged-long liquidations are driving the discussion. Traders are split between viewing the move as a bear trap near support and warning that continued selling could lead to a deeper decline.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Discussion centers on volatile Dow and broader-market moves amid rising Treasury yields, hawkish Fed concerns, and oil and Iran-related risks. Traders are split between expecting further losses and seeing the Dow show relative strength versus tech stocks, with some also watching for sector rotation.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs co-founders planning to leave and start a new mRNA venture, alongside weak results and a reduced revenue outlook, have weighed on sentiment. Traders debate whether leadership and execution risks outweigh the companys cash reserves and oncology pipeline, including recent positive data for an experimental cancer drug.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Discussion is fragmented across AstraZenecas cancer-drug developments and broader pipeline news, including Zegfrovys accelerated FDA approval and positive Phase 3 results for Tezspire with Amgen. Traders also debate the stocks weakness and speculate about biotech acquisitions, but the buyout claims are unconfirmed.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoins sharp swings and reported leveraged-position liquidations dominate the discussion, with bearish traders warning of further selling while bulls point to support and potential rebounds. Macro conditions, ETF flows and crypto-policy developments also feature as possible influences, but sentiment remains divided.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Discussion centers on Phase 1 atopic dermatitis results for Corvuss soquelitinib, which bullish traders view as promising while others question the small cohorts and limited follow-up on durability and safety. The datas release was met with a sharp sell-the-news reaction, prompting debate over the disconnect and renewed claims that heavy short interest is weighing on the shares.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BABA Stock Slips Overnight: Alibaba’s AI Spending Draws Investor Scrutiny, Analysts Split

Equity

As investors question Alibaba’s  $10.2 billion equity raise and AI spending returns, Bernstein cut its price target, but Bank of America raised its outlook on cloud growth. 


BIDU's GPU Cloud Revenue Soars 283% In Q2 — CEO Says AI Business Is Now 'Firmly Established As The Core'

Baidu’s AI Cloud Infrastructure revenue rose 50% year-on-year to RMB7.3 billion in the second quarter, driven by “mounting demand for public cloud-based AI computing,” the company said.


BABA Stock Gains Ground: Alibaba Reportedly Sells Gaming Unit For $1.5B As Qwen Fuels Bigger AI Push

The move comes as Alibaba's Qwen models surpass 3 billion downloads, putting its open-source AI push in competition with U.S. players including Google and Meta.

Why Is BABA Stock Rising In Overnight Trading?

A U.S. court temporarily eased Pentagon-related restrictions on Alibaba, and the company tightened AI security. 

BABA Stock Slides: Alibaba Reportedly Sues Pentagon Over China Military-Linked Blacklist

Investors worry that geopolitical risks may lead to contract restrictions for the Chinese tech giant. 


BABA Stock Slides Premarket: Alibaba's New AI Push Into Robotics Fails To Lift Retail Mood 

Alibaba’s announcement places it among a growing list of companies seeking leadership positions in next-generation AI technologies.


Michael Burry Boosts Alibaba Stake, Calls It China's 'Most Advanced' AI Company — BABA Stock Still Stuck In The Mud

Michael Burry increased his Alibaba stake at $111.90, citing its AI leadership and buybacks. 


BABA Stock Heads For Fifth Week Of Loss: Alibaba Reportedly Makes $1.5B Play For Pupu Amid China Regulatory Scrutiny

Stock is facing pressure from regulatory scrutiny, intense e-commerce competition, and heavy AI spending.


Alibaba Opens Qwen To Brands – Aims To Build AI-Powered Commerce Network 

Alibaba is expanding its Qwen AI platform to let businesses offer ordering and payments inside chat. 


Iran War Fails to Dampen China Q1 Industrial Profit Jump: ETFs at Play

China's industrial profit surge puts the spotlight on ETFs like CQQQ as deflation ends and high-tech growth drives resilience amid global turmoil.

Invesco Exchange-Traded Fund Trust - Invesco Golden Dragon China ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Bernstein lowered its Alibaba price target to $165 from $180 but kept an Outperform rating.</li><li>Bernstein believes Alibaba can still generate good returns from its spending despite investor concerns over the share sale.&nbsp;</li><li>Bank of America raised Alibaba’s price target to $175 from $172, implying a 54% upside.&nbsp;</li></ul><p>Alibaba Group (BABA) stock slipped overnight as investors weighed concerns over the company's recent $10.2 billion equity raise and whether its aggressive AI spending can deliver attractive returns. Wall Street offered mixed signals, with Bernstein lowering its price target while Bank of America raised its price target on stronger cloud growth expectations.&nbsp;</p><p><a href="https://stocktwits.com/symbol/BABA">Alibaba stock</a> traded over 1% lower overnight, ahead of Tuesday. The stock fell more than 4% last week, marking a fourth straight week of losses.&nbsp;</p><h2 class="st-heading-2">Bernstein Cuts Alibaba Price Target&nbsp;</h2><p>On Monday, Bernstein cut its price target for Alibaba to $165 from $180 while maintaining an ‘Outperform’ rating, still implying a 45% upside to the stock’s last closing price. The firm acknowledged investor frustration over the capital raise, particularly because Alibaba held $30.7 billion in net cash when it announced the deal.</p><p>Bernstein said the transaction weakened confidence in management's previous arguments about returns on investment. However, the firm's own review largely backs Alibaba's expectations for recovering the money it spends on capital projects, suggesting the company's spending strategy could still generate reasonable paybacks.</p><h2 class="st-heading-2">Alibaba’s Cloud Expansion Could Boost Future Earnings&nbsp;</h2><p>Bank of America took a more optimistic view. Analyst Joyce Ju lifted her price target to $175 from $172 and kept a ‘Buy’ rating, implying a 54% upside to the stock’s last closing price. She said investors are increasingly focused on whether Alibaba can turn its AI spending into stronger and more profitable cloud operations.</p><p>Ju raised BofA's outlook for Alibaba's cloud revenue growth in fiscal 2027 through fiscal 2029 to 51%, 56% and 41%, respectively. The forecasts assume newly added computing capacity will support revenue from outside customers and contribute to earnings beginning in fiscal 2028.</p><h2 class="st-heading-2">Alibaba Leaders Show Confidence With Stock Buying&nbsp;</h2><p>Late last month, Alibaba sold 710 million shares at HK$112.70 ($15.65) each, drawing strong interest from institutional investors, with demand reaching nearly three times the number of shares available. Alibaba plans to use the money to expand its AI business, including building and improving the infrastructure needed to support its AI technology.</p><p>Following the share sale, Alibaba founder Jack Ma bought more than HK$600 million worth of Alibaba shares in Hong Kong. A similar move was made by Chairman Joe Tsai and CEO Eddie Wu, who together bought about HK$202 million of Alibaba shares.&nbsp;</p><h2 class="st-heading-2">BABA Stock: Retail Stance</h2><p>On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;</p><p>BABA stock has declined over 22% year-to-date.&nbsp;</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/birk-stock-rises-overnight-michael-burry-says-he-s-been-a-proud-birkie-since-87-and-now-owns-5-2-of-birkenstock/cZt3N10RJxx">BIRK Stock Rises Overnight: Michael Burry Says He’s Been A 'Proud Birkie Since '87' – And Now Owns 5.2% Of Birkenstock</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

A person holds a smartphone displaying the logo of Alibaba Group. CEO Eddie Wu said the company will increase investment in AI. (Photo by Cheng Xin/Getty Images)

As investors question Alibaba’s  $10.2 billion equity raise and AI spending returns, Bernstein cut its price target, but Bank of America raised its outlook on cloud growth.

Alibaba Group Holding Ltd

ProShares Online Retail ETF

Invesco Golden Dragon China ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$21.12
Prev Close	$21.31
Open	$21.32
Dividend Yield	N/A
50-Day Moving Average	$22.63
Beta	N/A
Avg. Volume	21,890.56
PE Ratio	N/A

52-Week High	$32.93
52-Week Low	$21.05
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

PGJ Fundamentals